An antibody (Ab), also known as an immunoglobulin (Ig), is a large, Y-shaped protein used by the immune system to identify and neutralize foreign objects such as pathogenic bacteria and viruses. The antibody recognizes a unique molecule of the pathogen, called an antigen. Each tip of the "Y" of an antibody contains a paratope that is specific for one particular epitope on an antigen, allowing these two structures to bind together with precision. Using this binding mechanism, an antibody can tag a microbe or an infected cell for attack by other parts of the immune system, or can neutralize it directly.
Group 3 is the first group of transition metals in the periodic table. This group is closely related to the rare-earth elements. It contains the four elements scandium (Sc), yttrium (Y), lutetium (Lu), and lawrencium (Lr). The group is also called the scandium group or scandium family after its lightest member.
90Y-DOTA-biotin consists of a radioactive substance (yttrium-90) complexed by a chelating agent (DOTA), which in turn is attached to the vitamin biotin via a chemical linker. It is used experimentally in pretargeted radioimmunotherapy. Animal studies have been conducted as well as clinical studies in humans.
Yttrium oxide, also known as yttria, is Y2O3. It is an air-stable, white solid substance.
Natural yttrium (39Y) is composed of a single isotope yttrium-89. The most stable radioisotopes are 88Y, which has a half-life of 106.6 days and 91Y with a half-life of 58.51 days. All the other isotopes have half-lives of less than a day, except 87Y, which has a half-life of 79.8 hours, and 90Y, with 64 hours. The dominant decay mode below the stable 89Y is electron capture and the dominant mode after it is beta emission. Thirty-five unstable isotopes have been characterized.
Ibritumomab tiuxetan, sold under the trade name Zevalin, is a monoclonal antibody radioimmunotherapy treatment for non-Hodgkin's lymphoma. The drug uses the monoclonal mouse IgG1 antibody ibritumomab in conjunction with the chelator tiuxetan, to which a radioactive isotope is added. Tiuxetan is a modified version of DTPA whose carbon backbone contains an isothiocyanatobenzyl and a methyl group.
Radioimmunotherapy (RIT) uses an antibody labeled with a radionuclide to deliver cytotoxic radiation to a target cell. It is a form of unsealed source radiotherapy. In cancer therapy, an antibody with specificity for a tumor-associated antigen is used to deliver a lethal dose of radiation to the tumor cells. The ability for the antibody to specifically bind to a tumor-associated antigen increases the dose delivered to the tumor cells while decreasing the dose to normal tissues. By its nature, RIT requires a tumor cell to express an antigen that is unique to the neoplasm or is not accessible in normal cells.
Yttrium(III) fluoride is an inorganic chemical compound with the chemical formula YF3. It is not known naturally in 'pure' form. The fluoride minerals containing essential yttrium include tveitite-(Y) (Y,Na)6Ca6Ca6F42 and gagarinite-(Y) NaCaY(F,Cl)6. Sometimes mineral fluorite contains admixtures of yttrium.
Yttrium(III) bromide is an inorganic compound with the chemical formula YBr3. It is a white solid. Anhydrous yttrium(III) bromide can be produced by reacting yttrium oxide or yttrium(III) bromide hydrate and ammonium bromide. The reaction proceeds via the intermediate (NH4)3YBr6. Another method is to react yttrium carbide (YC2) and elemental bromine. Yttrium(III) bromide can be reduced by yttrium metal to YBr or Y2Br3. It can react with osmium to produce Y4Br4Os.
Pemtumomab is a mouse monoclonal antibody used to treat cancer. The substance has affinity to various types of cancer, like ovarian cancer and peritoneal cancer, via the polymorphic epithelial mucin and delivers the radioisotope Yttrium-90 into the tumour. As of 2009, it is undergoing Phase III clinical trials.
Indium (111In) capromab pendetide is used to image the extent of prostate cancer. Capromab is a mouse monoclonal antibody which recognizes a protein found on both prostate cancer cells and normal prostate tissue. It is linked to pendetide, a derivative of DTPA. Pendetide acts as a chelating agent for the radionuclide indium-111. Following an intravenous injection of Prostascint, imaging is performed using single-photon emission computed tomography (SPECT).
TheraSphere is a radiotherapy treatment for hepatocellular carcinoma (HCC) that consists of millions of microscopic, radioactive glass microspheres being infused into the arteries that feed liver tumors. These microspheres then embolize, lodging themselves in the liver's capillaries and bathing the malignancy in high levels of yttrium-90 radiation. It is currently approved as a Humanitarian Device, meaning effectiveness has not been proven, for patients as a neoadjuvant to surgery or transplantation by the U.S. Food and Drug Administration and is being used at a number of clinical centers in the United States.
Yttrium is a chemical element with the symbol Y and atomic number 39. It is a silvery-metallic transition metal chemically similar to the lanthanides and has often been classified as a "rare-earth element". Yttrium is almost always found in combination with lanthanide elements in rare-earth minerals, and is never found in nature as a free element. 89Y is the only stable isotope, and the only isotope found in the Earth's crust.
DOTA (also known as tetraxetan) is an organic compound with the formula (CH2CH2NCH2CO2H)4. The molecule consists of a central 12-membered tetraaza (i.e., containing four nitrogen atoms) ring. DOTA is used as a complexing agent, especially for lanthanide ions. Its complexes have medical applications as contrast agents and cancer treatments.
Yttrium-90 is an isotope of yttrium. Yttrium-90 has found a wide range of uses in radiation therapy to treat some forms of cancer.
Yttrium (90Y) clivatuzumab tetraxetan is a humanized monoclonal antibody-drug conjugate designed for the treatment of pancreatic cancer. The antibody part, clivatuzumab, is conjugated with tetraxetan, a chelator for yttrium-90, a radioisotope which destroys the tumour cells.
Yttrium phosphide is an inorganic compound of yttrium and phosphorus with the chemical formula YP. The compound may be also classified as yttrium(III) phosphide.
Yttrium(III) nitrate is an inorganic compound, a salt with the formula Y(NO3)3. The hexahydrate is the most common form commercially available.
An yttrium compound is a chemical compound containing yttrium. Among these compounds, yttrium generally has a +3 valence. The solubility properties of yttrium compounds are similar to those of the lanthanides. For example oxalates and carbonates are hardly soluble in water, but soluble in excess oxalate or carbonate solutions as complexes are formed. Sulfates and double sulfates are generally soluble. They resemble the "yttrium group" of heavy lanthanide elements.
(what is this?) (verify) 
